Stroke Journal

JANUARY 30, 2025

Introduction:Pediatric heart transplant (PHT) recipient survival has improved. Yet, neurologic morbidity related to heart failure and its treatment persist. It can affect the functional outcome, increase risk of major adverse events, prolong LOS and increase the use of rehabilitation therapies (RT).

Heart Transplant 40

Heart Transplant Transplant Pediatrics Stroke 40

DAIC

MARCH 6, 2024

Food and Drug Adminstration (FDA) has approved DEFINITY (Perflutren Lipid Microsphere) as an ultrasound enhancing agent for use in pediatric patients with suboptimal echocardiograms, including those who have undergone heart transplant, or have Kawasaki disease or a congenital cardiovascular anomaly. 5 Kutty, S., et al (2016).

Pediatrics 105

Pediatrics Ultrasound Heart Transplant Echocardiogram 105

Circulation

NOVEMBER 11, 2024

End-stage ischemic heart disease necessitates heart transplantation, and emerging cell therapy presents a promising solution to address donor scarcity. Disruption of gut microbiota significantly influences various diseases and treatments, including transplantation.

Ischemia 40

Ischemia Transplant Heart Transplant Biomarkers 40

Circulation: Arrhythmia and Electrophysiology

FEBRUARY 12, 2024

This study aimed to investigate the early and late efficacy, survival, and safety of CRT in patients with tetralogy of Fallot.METHODS:Data were analyzed from an observational, retrospective, multicenter cohort, initiated jointly by the Pediatric and Congenital Electrophysiology Society and the International Society of Adult Congenital Heart Disease.

Congenital Heart Disease 40

Congenital Heart Disease Outcomes Electrophysiology Congenital 40

Frontiers in Cardiovascular Medicine

FEBRUARY 19, 2025

Cardiovascular diseases (CVDs), characterized by a high incidence rate and high mortality, have become the leading cause of death globally. CVDs include coronary heart disease, stroke, hypertension, and peripheral vascular diseases. In China, the death rate of CVDs ranks the first in all major diseases.

Myocardial Infarction 52

Myocardial Infarction Quality of Life Heart Transplant Ischemia 52

Circulation

JANUARY 9, 2025

BACKGROUND:The United Network of Organ Sharing made changes to the priority for allocation of hearts for transplantation (HT) in 2016 for pediatric patients and 2018 for adult patients.

Congenital Heart Disease 49

Congenital Heart Disease Pediatrics Cardiomyopathy Transplant 49

Journal of the American Heart Association

DECEMBER 12, 2023

BackgroundScreening for cardiovascular disease is currently recommended before kidney transplantation. Outcomes were degree of coronary heart disease, revascularization rate following screening, major adverse cardiovascular events, and all‐cause death. 10.8]; and HR, 2.1 [95% 3.9]) and all‐cause death (HR, 12.0 [95%

Transplant 40

Transplant Heart Disease Cardiovascular Disease Outcomes 40

Circulation: Heart Failure

FEBRUARY 1, 2024

BACKGROUND:In 2018, an algorithm-based allocation system for heart transplantation (HT) was implemented in France. The cumulative incidence of waitlist mortality estimated with competing risk analysis and incidence of transplantation were compared between diagnosis groups. 2.58];P=0.94; congenital heart disease, 1.82 [95% CI, 0.78–4.26];P=0.17).

Heart Failure 40

Heart Failure Congenital Heart Disease Congenital Cardiomyopathy 40

Journal of Cardiovascular Electrophysiology

DECEMBER 17, 2024

The composite outcome of VT/VF recurrence, heart transplantation, or death occurred in 6/12 patients (50%) without dofetilide and 49/69 patients (71%) with dofetilide. Dofetilide had to be discontinued in 50/69 patients (72%) due to inefficacy or intolerance.

Tachycardia 40

Tachycardia Heart Disease Atrial Flutter Heart Transplant 40

Circulation: Cardiovascular Imaging

DECEMBER 16, 2024

Noninvasive surrogates for RVAC using echocardiographic estimates of right ventricular function, such as tricuspid annular plane systolic excursion (TAPSE), have been shown to correlate with invasively measured RVAC and predict clinical outcomes in pediatric pulmonary arterial hypertension.

Pediatrics 40

Pediatrics Pulmonary Congenital Heart Disease Hypertension 40

Cardiometabolic Health Congress

AUGUST 8, 2024

This blog post explores the development of such partnerships and their potential to transform healthcare outcomes. 4 Keys To Partnering With Patients: The Cornerstone of Effective Cardiorenal Metabolic Management At the heart of any successful healthcare intervention lies the patient.

Education 59

Education Cardiovascular Disease Diabetes Kidney Disease 59

Journal of the American Heart Association

NOVEMBER 28, 2023

BackgroundDespite improvements in survival over time, the mortality rate for infants with single‐ventricle heart disease remains high. Hierarchical logistic regression, adjusted for potential confounding characteristics, was used to determine the association between SES and death or transplant listing during the interstage period.

Heart Disease 40

Heart Disease Transplant Technology Outcomes 40

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Adult Cardiac Surgery Database Lead Author Title Publication Date Jacob Raphael Red Blood Cell Transfusion and Pulmonary Complications: The Society of Thoracic Surgeons Adult Cardiac Surgery Database Analysis The Annals of Thoracic Surgery January 2024 Joseph Sabik Multi-Arterial versus Single-Arterial Coronary Surgery: Ten Year Follow-up of One Million (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Program Designations Access and Publications (A&P) 1 Participant User File (PUF) 2 Task Force on Funded Research (TFR) 3 Special Projects 4 Adult Cardiac Surgery Database Lead Author Title Publication Date William Keeling 2 National Trends in Emergency Coronary Artery Bypass Grafting European Journal of Cardiothoracic Surgery October 2023 Jake (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Dr. Malcolm Kendrick

OCTOBER 30, 2024

The hypothesis that a raised cholesterol level causes heart disease [atherosclerotic cardiovascular disease (ASCVD)] is possibly the single most powerful idea in medicine. And if you dare to suggest the idea that low-fat foods do not protect against heart disease, you get much the same treatment.

Cholesterol 145

Cholesterol Article Research Diet 145